Recombinant Ranavirus, Methods of Production, and Its Use As A Mammalian Expression System

Wearable device and method for visual image adjustment

Myxoma virus compositions and methods of use

Recombinant modified vaccinia virus ankara (MVA) equine encephalitis virus vaccine

Immunogenic composition comprising a recombinant attenuated mopeia virus with a modified nucleoprotein displaying reduced exonuclease activity

Recombinant Modified Vaccinia Virus Ankara (MVA) Respiratory Syncytial Virus (RSV) Vaccine

Broad spectrum influenza virus vaccine

Genetically engineered foot and mouth disease virus and related proteins, polynucleotides, compositions, methods and systems

Rapid method of generating live attenuated vaccines

Stable vaccine compositions comprising inter alia live attenuated recombinant flavivirus and process for preparation thereof

MVA vaccine for delivery of a UL128 complex and preventing CMV infection

Recombinant respiratory syncytial virus strains comprising NS1 and NS2 gene shifts

Methods for Introducing Mutations That Alter the Probability of Intranucleic Acid Base Pairing of a Conserved Structured Nucleotide and Related Compositions

Triple vaccine against and avian encephalomyelitis virus and fowl pox virus

Diluent for cell-associated alphaherpesvirus vaccine

Chimeric viruses encoding mutant zika virus envelope glycoproteins

complex outer membrane vesicles as adjuvants

Hepatitis B immunization regimen and compositions

Live-attenuated yellow fever virus strain adapted to grow on Vero cells and vaccine composition comprising the same

Recombinant chimeric bovine/human parainfluenza virus 3 expressing RSV G and its use

TRI-SEGMENTED ARENAVIRUSES AS VACCINE VECTORS

Method for preserving biopharmaceuticals

ANTI-TUMORAL COMPOSITION

VACCINE COMPOSITION

Compositions and methods for stabilizing flaviviruses with improved formulations

Live attenuated Arkansas serotype infectious bronchitis virus vaccine

Recombinant Herpes Simplex Virus-2 expressing glycoprotein B and D antigens

Therapeutic vaccine for the treatment of papillomavirus lesions

Recombinant RSV with silent mutations, vaccines, and methods related thereto

Methods for generating a Zikv immune response utilizing a recombinant modified vaccina Ankara vector encoding the NS1 protein

Recombinant host cell with heterologous nucleic acids encoding SHREK proteins

Zika virus purification

Development of a novel live attenuated African Swine Fever vaccine based in the deletion of gene I177L

Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

Smallpox vaccine for cancer treatment

Influenza virus vectors and uses therefor

Antigen purification

Attenuated flaviviruses

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

RSV vaccines and methods of production and use thereof

TROPISM MODIFIED CANCER TERMINATOR VIRUS (AD.5/3 CTV;AD.5/3-CTV-M7)

Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4

ADDITION OF NUCLEASES DIRECTLY TO CELL CULTURE TO FACILITATE DIGESTION AND CLEARANCE OF HOST CELL NUCLEIC ACIDS

FORMULATIONS OF DENGUE VIRUS VACCINE COMPOSITIONS

METHOD TO PRODUCE A MEDICINAL PRODUCT COMPRISING A BIOLOGICALLY ACTIVE PROTEIN AND THE RESULTING PRODUCT

Zika virus vaccine

Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors

CHIKV RNA vaccines

Virus purification

COMPOSITIONS AND METHODS FOR PRODUCING DENDRITIC CELLS

Aseptic purification process for viruses

Vaccines against genital herpes simplex infections

Methods of manufacturing an immunogenic composition comprising a recombinant protein

Rapid and prolonged immunogic therapeutic

Rapid and prolonged immunologic therapeutic

Recombinant non-pathogenic Marek's Disease virus constructs encoding multiple heterologous antigens

Development of dengue virus vaccine components

Methods of vaccine administration

Method of inhibiting enveloped virus binding to target cells by incorporating P-selectin glycoprotein ligand-1 (PSGL-1) into virions

Chimeric yellow fever ZIKA virus strain

COMPOSITIONS AND METHODS FOR STABILIZING ALPHAVIRUSES WITH IMPROVED FORMULATIONS

Method and system for inactivating virus infectivity for producing live-attenuated vaccines

Vaccine to pathogenic immune activation cells during infections

Alphavirus and compositions, methods, and kits related thereto

System and method for image generation based on a display-attachable wearable device

Chikungunya virus RNA vaccines

Zika virus RNA vaccines

Recombinant respiratory syncytial virus strains with mutations in the M2-2 ORF providing a range of attenuation phenotypes

ORF7 deficient varicella virus, vaccine comprising the virus and use thereof

Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a chimeric RSV/HPIV1 F protein and uses thereof

Combination immunotherapies for treatment of cancer

Modulation of replicative fitness by deoptimization of synonymous codons

Non-neuroinvasive viruses and uses thereof

Non-neuroinvasive viruses and uses thereof

Influenza viruses with mutant PB2 gene segment as live attenuated vaccines

Generation of infectious influenza viruses from virus-like particles

virulence factor compositions

Recombinant measles virus expressing zika virus prM and E proteins

Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors

Effective vaccination against porcine reproductive and respiratory syndrome (PRRS) virus prior to weaning

Glycosylated analogues of Flavivirus E proteins and their use in diagnostic methods

NS1 truncated virus for the development of canine influenza vaccines

Recombinant viral vector systems expressing exogenous feline paramyxovirus genes and vaccines made therefrom

North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof

Virus purification

Attenuated porcine sapelovirus strain and immunogenic compositions therefrom

Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine

CMV-based intra-tumoral cancer therapies

Methods and compositions for dengue virus serotype 4 epitopes

LIVE ATTENUATED VIRUS VACCINES FOR LA CROSSE VIRUS AND OTHER BUNYAVIRIDAE

Virus causing respiratory tract illness in susceptible mammals

Phenotypically wild-type and genetically attenuated viruses

Attenuated african swine fever virus vaccine

Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers

Human rotavirus G9P[6] strain and use as a vaccine

METHODS TO REDUCE THE LIKELIHOOD OF MATERNAL AND FETAL ZIKA VIRUS DISEASE

Alphavirus Replicon Particles Expressing TRP2

Methods and compositions for live attenuated viruses

Human cytomegalovirus comprising exogenous antigens

Apparatus for releasably holding a socket

Intranasal vector vaccine against porcine epidemic diarrhea

Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein

Combination vaccine for swine

MVA vaccine for delivery of a UL128 complex and preventing CMV infection

Porcine parainfluenza virus type 1 isolates and immunogenic compositions therefrom

Influenza virus mutants and uses therefor

Compositions and Methods for Dengue Virus Chimeric Constructs in Vaccines

CATIONIC NANOPARTICLES FOR ENHANCING INFECTIOUS CAPACITY OF LIVE VIRUSES

Human rotavirus strains and vaccines

Vaccines containing swine pathogens for associated non-mixed use

P53-targeting vaccines and pd-1 pathway inhibitors and methods of use thereof

Addition of nucleases directly to cell culture to facilitate digestion and clearance of host cell nucleic acids

Immunization agents and methods of use

Methods and compositions for inducing protective immunity against filovirus infection

Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

System and method and device for adjusting image positioning

Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors

Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus

DEVELOPMENT OF AN ALTERNATIVE MODIFIED LIVE INFLUENZA B VIRUS VACCINE

Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy

Heat stable vaccines

Compositions and methods of vaccination against dengue virus in children and young adults

Virus purification

Virus and antigen purification and conjugation

Effective vaccination against European strains of porcine reproductive and respiratory syndrome (PRRS) virus prior to weaning

Alphavirus NSP mutants as vaccines

Effective vaccination against porcine reproductive and respiratory syndrome (PRRS) virus prior to weaning

Purification of herpes virus

Recombinant virus, composition comprising the same, and uses thereof

Universal mammalian influenza vaccine

Vaccines against infectious diseases caused by positive stranded RNA viruses

Multivalent recombinant SPV

Modified flavivirus envelope sequences comprising unique glycosylation sites

Dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection

Chimeric west nile/zika viruses and methods of use

Combination immunotherapies for treatment of cancer

Immune modulator and vaccine composition containing the same

Tropism modified cancer terminator virus (Ad.5/3 CTV;Ad.5/3-CTV-M7)

Genetically stable live attenuated respiratory syncytial virus vaccine and its production

Plasmodium with histamine releasing factor (HRF) deficiency for use as a vaccine

Affenadenovirus (gorilla) or adenoviral vectors and methods of use

Vaccine composition

Vaccine compositions comprising an attenuated mutant Zika virus

CMV vaccines

Passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) vaccine vectors

Method and system for inactivating virus infectivity for producing live-attenuated vaccines

HPV vaccines

PESTIVIRUS MARKER VACCINE

Vaccine composition

Compositions and methods for enhancing growth, spread, and oncolytic and immunotherapeutic efficacy of oncolytic RNA viruses

Recombinant RSV with silent mutations, vaccines, and methods related thereto

RSV vaccines and methods of production and use thereof

Modified Marek's disease virus, and vaccines made therefrom

Recombinant mumps virus vaccine

Transgenic VERO-CD4/CCR5 cell line

Tilapia lake virus vaccines

Processing engineered FMDV P1 polypeptide using an alternative TEV protease

Compositions and methods for generating reversion free attenuated and/or replication incompetent vaccine vectors

Porcine epidemic diarrhea preventative or therapeutic method, vaccine, and vaccine kit

LIVE ATTENUATED ZIKA VIRUS VACCINE

Microparticulated Vaccines for the Oral or Nasal Vaccination and Boostering of Animals Including Fish

FLAVIVIRUS VACCINES

Live attenuated recombinant HMPV with mutations in PDZ motifs of M2-2 protein, vaccine containing and use thereof

Compositions and methods for stabilizing flaviviruses with improved formulations

Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseases

Recombinant respiratory syncytial virus strains comprising NS1 and NS2 gene shifts

Porcine reproductive and respiratory syndrome virus cDNA clone and uses thereof

Genomic sequences encoding for an attenuated mutant Zika virus

Respiratory syncytial virus having altered NS1 protein function and related materials and methods

Recombinant virus with diminished latency and methods of using same

Method of enhancing innate immune responses against a tumor comprising administering lymphocytic choriomeningitis virus (LCMV)

Compositions, methods and uses for dengue virus serotype-4 constructs

PRRS virus variant, european PRRS virus cDNA clone, and uses thereof

Buffer free, acid stable low dose volume rotavirus vaccine

Arthrogenic alphavirus vaccine

Compositions and methods for live, attenuated alphavirus formulations

European PRRSV strain

RAPID AND PROLONGED IMMUNOGENIC-THERAPEUTIC

COMPOSITIONS AND METHODS FOR TUMOR VACCINATION AND IMMUNOTHERAPY INVOLVING HER2/NEU

HIV-1 vaccine

Equine influenza virus live attenuated vaccines

Cold adapted and virulence factor deleted live attenuated vaccine suitable for mucosal delivery

RAPID METHOD OF GENERATING LIVE ATTENUATED VACCINES

Virus causing respiratory tract illness in susceptible mammals

Development of dengue virus vaccine components

Vaccine against beta-herpesvirus infection and use thereof

Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine

Live attenuated virus vaccines for La Crosse virus and other bunyaviridae

Vaccines comprising mutant attenuated influenza viruses

Substitutions-modified prefusion RSV F proteins and their use

Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors

Synergistic co-administration of computationally optimized broadly reactive antigens for human and avian H5N1 influenza

BACTERIAL ARTIFICIAL CHROMOSOMES

Compositions and methods for stabilizing alphaviruses with improved formulations

Method of long-term preservation of chemical and biological species using sugar glasses

Live, Attenuated Alphavirus Constructs and Methods and Uses Thereof

METHOD OF MAKING A VACCINE

Method of making a vaccine

Vaccine for intradermal application against PCV2 and PRRS virus infection

Recombinant HCMV and RHCMV vectors and uses thereof

Vaccines against genital herpes simplex infections

Human rotavirus G9P[6] strain and use as a vaccine

Combination vaccine against PCV2 and PRRS virus infection comprising albumin

Multivalent vaccines for rabies virus and coronaviruses

Type II pseudorabies virus attenuated strain, its preparation method and application

Reoviridae vaccine

Influenza virus mutants and uses therefor

Infectious disease vaccines

Recombinant respiratory syncytial virus stains with mutations in the M2-2 ORF providing a range of attenuation phenotypes

Mesenchymal stem cells as vaccine adjuvants and methods for using the same

Recombinant modified vaccinia virus Ankara (MVA) equine encephalitis virus vaccine

Recombinant Ranavirus, Methods of Production, and Its Use as a Human Vaccine Vector

Compositions and Methods for Generating an Immune Response to a Flavivirus

Attenuated infectious bronchitis virus

Porcine reproductive and respiratory syndrome vaccine virus

Attenuated viruses useful for vaccines

Adjuvant compositions

POULTRY VIRUS VACCINES THAT ARE LIQUID STABLE

Chikungunya virus RNA vaccines

Zika virus RNA vaccines

Zika virus purification

Attenuated virus having multiple hosts

Vaccine against bovine leukemia virus

Methods and compositions related to increasing the fidelity of influenza A virus for vaccine development

Thermally stable rotavirus vaccine formulations and methods of use thereof

PRRSV SX-105 strain and use thereof

Zika virus vaccine

Genetically engineered swine influenza virus and uses thereof

Compositions and methods for vaccination against influenza A virus

Virus purification

Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

METHOD TO PRODUCE A MEDICINAL PRODUCT COMPRISING A BIOLOGICALLY ACTIVE PROTEIN AND THE RESULTING PRODUCT

Virus purification

Zika virus purification

Compositions and methods for stabilization of active agents

Bovine herpesvirus type 1 (BoHV-1) vector against bovine respiratory disease complex

MODIFIED HUMAN ROTAVIRUSES AND USES THEREFOR

CHIKV RNA vaccines

DENV RNA VACCINES

Viable viruses with foreign tags

Multivalent dengue vaccine composition comprising a mixture of attenuated dengue viruses from different serotypes

Flavivirus Vaccine

Coronaviruses, vaccines comprising the same, and methods for preventing disease

Chimeric RSV, immunogenic compositions, and methods of use

Smallpox vaccine for cancer treatment

Tunable vaccine platform against pathogens of the paramyxovirus family

Genetically engineered Foot and Mouth Disease Virus and related proteins, polynucleotides, compositions, methods and systems

VACCINES AND DIAGNOSTICS FOR NOVEL PORCINE ORTHOREOVIRUSES

Engineered respiratory syncytial viruses with control of cell-to-cell virus transmission for enhanced safety of live virus vaccines

Prefusion RSV F proteins and their use

Method of vaccination with an attenuated RSV vaccine formulation

Recombinant human/bovine parainfluenza virus 3 (B/HPIV3) expressing a chimeric RSV/BPIV3 F protein and uses thereof

NEW ADJUVANT AND VACCINE COMPOSITION CONTAINING THE SAME

MVA vaccine for delivery of a UL128 complex and preventing CMV infection

Recombinant attenuated Mopeia virus comprising a modified nucleoprotein with reduced exonuclease activity

Porcine pestvirus, vaccines, and assays

H3 influenza A virus

ANTI-TUMORAL COMPOSITION

Bivalent swine influenza virus vaccine

Stable live attenuated recombinant dengue vaccine

Human cytomegalovirus comprising exogenous antigens

Zika RNA vaccines

CDNA clone-launched platform for high-yield production of inactivated zika virus

Attenuated virus mutated at sites of evolutionarily conserved RNA structure

Ebola virus disease vaccine taking human replication deficient adenovirus as vector

Modulation of replicative fitness by deoptimization of synonymous codons

Process for preparing an attenuated tetravalent dengue vaccine

Synthetic chimeric poxviruses

Methods of treating and preventing influenza infections

Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases

Methods and compositions for eliciting an immune response against hepatitis B virus

Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus

Human rotavirus vaccine strains and diagnostics

Reverse genetics systems

Altered avian virus for in-ovo inoculation and methods of use thereof

Methods and compositions for therapeutic agents

Heat stable liquid rotavirus vaccine

COMPOSITIONS, METHODS OF ADMINISTRATION AND USES FOR TRIVALENT DENGUE VIRUS FORMULATIONS

Attenuated influenza vaccines and uses thereof

Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

Live attenuated Arkansas serotype infectious bronchitis virus vaccine

Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization

ORF7 deficient varicella virus, vaccine comprising the virus and use thereof

Method for rapid generation of an attenuated RNA virus

Processing of a modified foot-and-mouth disease virus P1 polypeptide by an alternative protease

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

Concomitant dengue and yellow fever vaccination

COMPOSITIONS AND METHODS FOR MODULATING VIRAL INFECTION

Methods of making and using live attenuated viruses

Development of dengue virus vaccine components

Immortalized porcine alveolar macrophage

Non-gelatin vaccine protectant composition and live attenuated influenza vaccine

Vaccine against porcine parvovirus and porcine reproductive and respiratory syndrome virus and methods of production thereof

Attenuated swine influenza vaccines and methods of making and use thereof

Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof

IPN Virus Genome Mutations and Codon Interactions

Vaccine combination against multiple dengue virus serotypes and preparation and application thereof

Compositions containing ambient-temperature stable, inactivated but therapeutically active biopharmaceuticals and methods for formulation thereof

Aseptic purification process for viruses